Autoimmune Hepatitis Refractory to Treatment Due to Underlying Grave’s Disease
نویسندگان
چکیده
منابع مشابه
Hyperthyroidism due to Graves-Basedow disease in a woman refractory to thyroid hormones.
1. Little WC, Freeman GL. Pericardial disease. Circulation. 2006;113:1622--32. 2. Lorell BH. Pericardial diseases. In: Braunwald E, editor. Heart disease: a textbook of cardiovascular medicine. 5th ed. Philadelphia, PA: Saunders; 1997. p. 1478--534. 3. Troughton RW, Asher CR, Klein AL. Percarditis. Lancet. 2004;363:717--27. 4. Spodick DH. Acute cardiac tamponade. N Engl J Med. 2003;349:684. 5. ...
متن کاملQT Prolongation due to Graves' Disease
Hyperthyroidism is a highly prevalent disease affecting over 4 million people in the US. The disease is associated with many cardiac complications including atrial fibrillation and also less commonly with ventricular tachycardia and fibrillation. Many cardiac pathologies have been extensively studied; however, the relationship between hyperthyroidism and rate of ventricular repolarization manif...
متن کاملA case of autoimmune hepatitis combined with Graves' disease.
A 25-year-old woman presented with jaundice, palpitation, and weight loss of 5 kg during a period of 2 weeks. Laboratory tests showed elevated levels of liver enzymes (AST 1,282 IU/L, ALT 1,119 IU/L) and total bilirubin (6.4 mg/dL); negative for hepatitis virus infection; elevated serum levels of triiodothyronine (T3, 3.60 ng/dL), free thyroxine (fT4, 3.82 ng/dL), and lowered serum level of thy...
متن کاملSuccessful Treatment for Chronic Hepatitis C-Autoimmune Hepatitis Overlap Syndrome due to Daclatasvir and Asunaprevir
Persistent hepatitis C virus (HCV) infection may induce autoimmune diseases and chronic hepatitis C is sometimes accompanied by autoimmune hepatitis (AIH). However, we are worried about the treatment for chronic hepatitis C-AIH overlap syndrome because interferon-based antiviral therapies may enhance autoimmunity and immunosuppressive corticosteroid administration may promote viral replication....
متن کاملSuccessful treatment of refractory autoimmune hepatitis with rituximab.
Autoimmune hepatitis is a severe liver disease in which ~10% of patients do not respond to standard treatment. We describe a new rescue therapy using anti-CD20 monoclonal antibodies (rituximab). Complete remission was obtained and maintained by using low doses of immunosuppressive drugs with repeated anti-CD20 infusions.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cureus
سال: 2019
ISSN: 2168-8184
DOI: 10.7759/cureus.4598